Active Ingredient History
The keratinocyte growth factor (KGF), also known as FGF7, is a growth factor present in the epithelialization-phase of wound healing. In this phase, keratinocytes are covering the wound, forming the epithelium. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Mucositis (approved 2004)
Alopecia (Early Phase 1)
Asthma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Colonic Neoplasms (Phase 2/Phase 3)
Deglutition Disorders (Phase 2)
Epidermolysis Bullosa (Early Phase 1)
Graft vs Host Disease (Phase 2)
Head and Neck Neoplasms (Phase 3)
Healthy Volunteers (Phase 1)
Hematologic Neoplasms (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 1)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 1/Phase 2)
Intestinal Neoplasms (Phase 2)
Leukemia (Phase 3)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Plasma Cell (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 3)
Lymphoma, Non-Hodgkin (Phase 4)
Mucositis (Phase 3)
Multiple Myeloma (Phase 4)
Multiple Sclerosis (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Neuroepithelial (Early Phase 1)
Pain (Phase 3)
Plasmacytoma (Phase 2)
Primary Myelofibrosis (Phase 2)
Sarcoma (Phase 2)
Stevens-Johnson Syndrome (Phase 1/Phase 2)
Stomatitis (Phase 3)
X-Linked Combined Immunodeficiency Diseases (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
